Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
The Company’s Common
Stock is traded on the Nasdaq Global Market, under the symbol “ CPSS.”
As of January 1, 2023, there were 28 holders of record of the Company’s Common Stock.
To date, we have not declared
or paid any dividends on our Common Stock. The payment of future dividends, if any, on our Common Stock is within the discretion of the
Board of Directors and will depend upon our income, capital requirements and financial condition, and other relevant factors. The instruments
governing our outstanding debt place certain restrictions on the payment of dividends. We do not intend to declare any dividends on our
Common Stock in the foreseeable future, but instead intend to retain any cash flow for use in our operations.
The table below presents information regarding
outstanding options to purchase our Common Stock as of December 31, 2022:
Plan category
Number of securities to be issued upon
exercise of outstanding options, warrants and rights
Weighted average exercise price of
outstanding options, warrants and rights
Number of securities remaining
available for future issuance under equity compensation plans
Equity compensation plans approved by security holders
11,167,329
$ 5.21
2,661,330
Equity compensation plans not approved by security holders.
–
–
–
Total
11,167,329
$ 5.21
2,661,330
Issuer Purchases of Equity Securities in the
Fourth Quarter
Period(1)
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)
Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
October 2022
315,800
$ 6.46
315,800
$ 10,863,384
November 2022
178,611
7.85
178,611
9,460,731
December 2022
135,552
8.25
135,552
8,342,529
Total
629,963
$ 7.24
629,963
(1) Each monthly period is the calendar month.
(2) Our board of directors authorized the purchase of $5.0 million, $10 million and $20 million of our
outstanding securities in January, March and July 2022, respectively. Through December 31, 2022, our board of directors had authorized
the purchase of up to $123.2 million of our outstanding securities, which program was first announced in our annual report for the year
2002, filed on March 26, 2003. All purchases described in the table above were under the plan announced in March 2003, which has
no fixed expiration date. As of December 31, 2022, we have purchased $109.9 million of our common stock representing 22,903,866 shares.
32
Item 6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.